ARTICLE | Company News
Galena Biopharma sales and marketing update
October 7, 2013 7:00 AM UTC
Galena launched Abstral fentanyl in the U.S. to treat breakthrough cancer pain. The wholesale acquisition cost is $881.28 for a 32-count package of 100 µg sublingual tablets. The initial starting dos...